Magainin Pharm (MAGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Magainin Pharm (MAGN)

MAGN 8.890

+2.2%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kech who wrote (90)	12/1/1997 6:44:00 PM
From: Shlepper	Read Replies (1) of 233

Tom, Sorry - I was bemoaning the fact that Medimmune has been generating cross applications for approved drugs, and Magainin could learn a lesson by setting up additional applications for Cytolex while the NDA process is approaching. I own Medimmune and have been impressed with the rapid pace of development once they got their first approval. I don't know if Cytolex is a good candidate for Psoriasis - it was just an intuitive rather than scientific idea. I still believe Magainin will one day make it big - particularly with their newer magainins, but they had better start regenerating some interest - they've been very quiet this past year, particularly regarding the NDA application. Those in the know still seem content with the progress of the company, so who am I to complain? Good Luck, Shep

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next